Stay updated on BCD-021 vs Avastin in NSCLC Clinical Trial
Sign up to get notified when there's something new on the BCD-021 vs Avastin in NSCLC Clinical Trial page.

Latest updates to the BCD-021 vs Avastin in NSCLC Clinical Trial page
- Check5 days agoChange DetectedNew site revision tag 'Revision: v3.3.3' was added and the 'HHS Vulnerability Disclosure' link along with the previous 'Revision: v3.3.2' were removed. These are routine site maintenance changes that do not affect trial information or navigation.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedDifference0.1%

- Check41 days agoChange DetectedThe government funding lapse notice/banner has been removed from the study page, and the study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check55 days agoChange DetectedThe screenshots show only minor UI/layout updates; there are no changes to fundamental study details such as design, eligibility criteria, interventions, outcomes, or enrollment. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check84 days agoChange DetectedKey updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.SummaryDifference3%

- Check91 days agoChange DetectedThe page version was updated from v3.0.2 to v3.1.0.SummaryDifference0.1%

Stay in the know with updates to BCD-021 vs Avastin in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BCD-021 vs Avastin in NSCLC Clinical Trial page.